Author Lázaro, Diana F.
-
2016 | Journal Article |
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation
Lázaro, D. F.; Dias, M. C.; Carija, A.; Navarro, S.; Madaleno, C. S.; Tenreiro, S. & Ventura, S. et al. (2016)
Acta Neuropathologica Communications, 4(1) art. 128. DOI: https://doi.org/10.1186/s40478-016-0402-8
Details DOI PMID PMC
-
2017 | Journal Article | Erratum
Correction: The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease
de Oliveira, R. M.; Vicente Miranda, H.; Francelle, L.; Pinho, R.; Szegö, É. M.; Martinho, R. & Munari, F. et al. (2017)
PLOS Biology, 15(4) pp. e1002601. DOI: https://doi.org/10.1371/journal.pbio.1002601
Details DOI
-
2020 | Preprint
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo
Dominguez-Meijide, A.; Parrales, V.; Vasili, E.; González-Lizárraga, F.; König, A.; Lázaro, D. F.& Lannuzel, A. et al. (2020). DOI: https://doi.org/10.1101/2020.11.06.371229
Details DOI
-
2020 | Book Chapter
The Interplay Between Proteostasis Systems and Parkinson’s Disease
Lázaro, D. F.& Outeiro, T. F. (2020)
In:Barrio, Rosa; Sutherland, James D.; Rodriguez, Manuel S. (Eds.), Proteostasis and Disease: From Basic Mechanisms to Clinics pp. 223-236. DOI: https://doi.org/10.1007/978-3-030-38266-7_9
Details DOI
-
2021 | Preprint
Super-resolution microscopy informs on the molecular architecture of alpha-synuclein inclusions in model systems and in the human brain
Weish, P.; Lázaro, D. F.; Palmares, L.; Santos, P. I.; Stadelmann, C. ; Höglinger, G. U.& Rizzoli, S. O. et al. (2021). DOI: https://doi.org/10.1101/2021.04.25.441304
Details DOI
-
2021 | Journal Article | Research Paper |
Identification of Two Novel Peptides That Inhibit α-Synuclein Toxicity and Aggregation
Popova, B.; Wang, D.; Rajavel, A.; Dhamotharan, K.; Lázaro, D. F.; Gerke, J. & Uhrig, J. F. et al. (2021)
Frontiers in Molecular Neuroscience, 14. DOI: https://doi.org/10.3389/fnmol.2021.659926
Details DOI PMID PMC